Colgate-Palmolive (NYSE:CL) Stock Rating Lowered by StockNews.com

StockNews.com downgraded shares of Colgate-Palmolive (NYSE:CLFree Report) from a buy rating to a hold rating in a report issued on Friday.

Several other research analysts have also weighed in on the company. UBS Group reduced their target price on Colgate-Palmolive from $104.00 to $100.00 and set a “buy” rating on the stock in a report on Monday, February 3rd. JPMorgan Chase & Co. lifted their target price on Colgate-Palmolive from $97.00 to $99.00 and gave the stock an “overweight” rating in a report on Friday. TD Cowen reduced their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. Morgan Stanley reduced their target price on Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Finally, Barclays reduced their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. One investment analyst has rated the stock with a sell rating, ten have given a hold rating and eleven have given a buy rating to the company’s stock. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $101.72.

Read Our Latest Report on Colgate-Palmolive

Colgate-Palmolive Stock Down 0.8 %

NYSE:CL opened at $89.80 on Friday. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. The firm has a market capitalization of $72.87 billion, a P/E ratio of 25.51, a P/E/G ratio of 4.20 and a beta of 0.40. The stock’s fifty day simple moving average is $89.02 and its 200-day simple moving average is $94.82.

Colgate-Palmolive (NYSE:CLGet Free Report) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. Colgate-Palmolive had a return on equity of 477.77% and a net margin of 14.38%. During the same period last year, the company posted $0.87 EPS. Equities research analysts expect that Colgate-Palmolive will post 3.75 earnings per share for the current year.

Institutional Trading of Colgate-Palmolive

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Axxcess Wealth Management LLC boosted its stake in Colgate-Palmolive by 0.3% during the 4th quarter. Axxcess Wealth Management LLC now owns 38,786 shares of the company’s stock valued at $3,526,000 after purchasing an additional 117 shares during the last quarter. Commonwealth Financial Services LLC boosted its stake in shares of Colgate-Palmolive by 4.5% in the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock worth $247,000 after buying an additional 118 shares during the last quarter. Wescott Financial Advisory Group LLC boosted its stake in shares of Colgate-Palmolive by 3.5% in the 4th quarter. Wescott Financial Advisory Group LLC now owns 3,517 shares of the company’s stock worth $320,000 after buying an additional 119 shares during the last quarter. D Orazio & Associates Inc. boosted its stake in shares of Colgate-Palmolive by 4.2% in the 4th quarter. D Orazio & Associates Inc. now owns 2,982 shares of the company’s stock worth $271,000 after buying an additional 120 shares during the last quarter. Finally, Lantz Financial LLC boosted its stake in shares of Colgate-Palmolive by 0.6% in the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock worth $1,831,000 after buying an additional 122 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Company Profile

(Get Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Read More

Analyst Recommendations for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.